Tradipitant for coronavirus infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Mar 2020: Trial registered, NCT04326426
  2. 13 Apr 2020: Trial started, NCT04326426

The trials

NCT04326426: ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

State
Under way
Phase
Phase 3
People
300 planned
Started
13 Apr 2020
Primary completion
1 Aug 2020
Arms
Tradipitant
Results
None posted
  1. 30 Mar 2020: Trial registered
  2. 13 Apr 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Nereus.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.